{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:56:06Z","timestamp":1792526166198,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018703","name":"European Innovation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vascn.2024.107498","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T11:46:08Z","timestamp":1709293568000},"page":"107498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Virtual clinical QT exposure-response studies \u2013 A translational computational approach"],"prefix":"10.1016","volume":"126","author":[{"given":"Jazmin","family":"Aguado-Sierra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Dominguez-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ani","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Butakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schaper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Kriegl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borje","family":"Darpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Rast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2024.107498_bb0005","doi-asserted-by":"crossref","unstructured":"Aguado-Sierra, J., Butakoff, C., Brigham R., Baron A. K., Houzeaux Guerra, J. M., Carreras, F., Filgueiras-Rama, D., Iaizzo, P. A., Iles, T. L. & Vazquez, M. HPC framework for in-silico trials on 3D virtual human cardiac population to assess drug-induced arrhythmic risk. MedRxiv, doi:https:\/\/doi.org\/10.1101\/2021.04.21.21255870 (2022).","DOI":"10.1101\/2021.04.21.21255870"},{"issue":"4","key":"10.1016\/j.vascn.2024.107498_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mcp.2000.105761","article-title":"Greater quinidine-induced QTc interval prolongation in women","volume":"67","author":"Benton","year":"2000","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.vascn.2024.107498_bb0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2165\/00003088-200241100-00004","article-title":"Clinical role of protein binding of quinolones","volume":"41","author":"Bergogne-B\u00e9r\u00e9zin","year":"2002","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/j.vascn.2024.107498_bb0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/pst.1567","article-title":"Effect of assay measurement error on parameter estimation in concentration-QTc interval modeling","volume":"12","author":"Bonate","year":"2013","journal-title":"Pharmaceutical Statistics"},{"key":"10.1016\/j.vascn.2024.107498_bb0025","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-3565(25)12319-7","article-title":"Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: Experimental profile of BRL-32872","volume":"276","author":"Bril","year":"1996","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/j.vascn.2024.107498_bb0030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11831-014-9126-8","article-title":"Alya: Computational solid mechanics for supercomputers","volume":"22","author":"Casoni","year":"2014","journal-title":"Archives of Computational Methods in Engineering"},{"key":"10.1016\/j.vascn.2024.107498_bb0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.vascn.2016.03.009","article-title":"An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panels","volume":"81","author":"Crumb","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2024.107498_bb0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome","volume":"80","author":"Curran","year":"1995","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.vascn.2024.107498_bb0045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cpt.60","article-title":"Results from the IQ-CSRC prospective study support replacement of the thorough QT study by QT assessment in the early clinical phase","volume":"97","author":"Darpo","year":"2015","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107498_bb0050","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bcp.12068","article-title":"Replacing the TQT study","volume":"76","author":"Darpo","year":"2013","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1016\/j.vascn.2024.107498_bb0055","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/bcp.12201","article-title":"Are women more susceptible than men to drug-induced QT prolongation? Concentration\u2013QTc modelling in a phase 1 study with oral rac-sotalol","volume":"77","author":"Darpo","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.vascn.2024.107498_bb0060","author":"Dofetilide"},{"issue":"4","key":"10.1016\/j.vascn.2024.107498_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/cnm.3185","article-title":"A rule-based method to model myocardial fiber orientation in cardiac biventricular geometries with outflow tracts","volume":"35","author":"Doste","year":"2019","journal-title":"International Journal for Numerical Methods in Biomedical Engineering"},{"issue":"6","key":"10.1016\/j.vascn.2024.107498_bb0070","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1161\/01.CIR.41.6.899","article-title":"Total excitation of the isolated human heart","volume":"41","author":"Durrer","year":"1970","journal-title":"Circulation"},{"key":"10.1016\/j.vascn.2024.107498_bb0075","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3389\/fphys.2017.00616","article-title":"Optimization of an in silico cardiac cell model for proarrhythmia risk assessment","volume":"8","author":"Dutta","year":"2017","journal-title":"Frontiers in Physiology"},{"issue":"2","key":"10.1016\/j.vascn.2024.107498_bb0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0002-8703(85)90585-X","article-title":"The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans","volume":"109","author":"Echizen","year":"1985","journal-title":"American Heart Journal"},{"issue":"8","key":"10.1016\/j.vascn.2024.107498_bb0085","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/0091270010381498","article-title":"Population pharmacokinetic and concentration-QTc models for moxifloxacin: Pooled analysis of 20 thorough qt studies","volume":"51","author":"Florian","year":"2019","journal-title":"The Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.vascn.2024.107498_bb0295","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cpt.2240","article-title":"Sex-specific classification of drug-induced torsade de pointes susceptibility using cardiac simulations and machine learning","volume":"110","author":"Fogli Iseppe","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107498_bb0090","first-page":"1","article-title":"Scientific white paper on concentration-QTc modeling","volume":"45","author":"Garnett","year":"2018","journal-title":"Journal of Pharmacokinetics and Pharmacodynamics"},{"key":"10.1016\/j.vascn.2024.107498_bb0095","doi-asserted-by":"crossref","unstructured":"Gonzalez-Martin, P., Sacco, F., Butakoff, C., Doste, R., Bederian, C., Espinosa Gutierrezde los Monteros, L.K., Houzeaux, G., Iaizzo, P.A., Iles, T.L., Vazquez, M. & Aguado-Sierra, J. (2022). Ventricular anatomical complexity and sex differences impact predictions from electrophysiological computational models. PLoS One, 18(2), e0263639. doi: 10.1371\/journal.pone.0263639.","DOI":"10.1371\/journal.pone.0263639"},{"issue":"17","key":"10.1016\/j.vascn.2024.107498_bb0100","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1016\/j.jcp.2009.05.019","article-title":"A massively parallel fractional step solver for incompressible flows","volume":"228","author":"Houzeaux","year":"2009","journal-title":"Journal of Computational Physics"},{"key":"10.1016\/j.vascn.2024.107498_bb0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3389\/fphys.2019.01139","article-title":"Three-dimensional heart model-based screening of proarrhythmic potential by in silico simulation of action potential and electrocardiograms","volume":"10","author":"Hwang","year":"2019","journal-title":"Frontiers in Physiology"},{"issue":"1","key":"10.1016\/j.vascn.2024.107498_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/clpt.1981.4","article-title":"Verapamil protein binding in patients and in normal subjects","volume":"29","author":"Keefe","year":"1981","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.vascn.2024.107498_bb0130","first-page":"627","article-title":"Cross-site and cross-platform variability of automated patch clamp assessments of drug effects on human cardiac currents in recombinant cells","volume":"10","author":"Kramer","year":"2020","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2024.107498_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/cpt.1647","article-title":"General principles for the validation of Proarrhythmia risk prediction models: An extension of the CiPA in silico strategy","volume":"107","author":"Li","year":"2019","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.vascn.2024.107498_bb0140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pbiomolbio.2020.06.007","article-title":"In-silico human electro-mechanical ventricular modelling and simulation for drug-induced pro-arrhythmia and inotropic risk assessment","volume":"159","author":"Margara","year":"2021","journal-title":"Progress in Biophysics and Molecular Biology"},{"issue":"3","key":"10.1016\/j.vascn.2024.107498_bb0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jelectrocard.2006.09.003","article-title":"Electrocardiographic reference ranges derived from 79,743 ambulatory subjects","volume":"40","author":"Mason","year":"2007","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.vascn.2024.107498_bb0150","doi-asserted-by":"crossref","unstructured":"Costabal FS., Matsuno K., Yao J., Perdikaris P., Kuhl E., Machine learning in drug development: Characterizing the effect of 30 drugs on the QT interval using Gaussian process regression, sensitivity analysis, and uncertainty quantification. Computer Methods in Applied Mechanics and Engineering 348, 313\u2013333. (2019).","DOI":"10.1016\/j.cma.2019.01.033"},{"issue":"1","key":"10.1016\/j.vascn.2024.107498_bb0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cvr\/cvr044","article-title":"Simulation of multiple ion channel block provides improved early prediction of compounds\u2019 clinical torsadogenic risk","volume":"91","author":"Mirams","year":"2011","journal-title":"Cardiovascular Research"},{"issue":"21","key":"10.1016\/j.vascn.2024.107498_bb0160","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1161\/01.CIR.102.21.2665","volume":"102","author":"Mounsey","year":"2000","journal-title":"Dofetilide. Circulation"},{"key":"10.1016\/j.vascn.2024.107498_bb0165","author":"Moxifloxacin"},{"issue":"10","key":"10.1016\/j.vascn.2024.107498_bb0170","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AAC.43.10.2345","article-title":"Penetration of moxifloxacin into peripheral compartments in humans","volume":"43","author":"M\u00fcller","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1\u20133","key":"10.1016\/j.vascn.2024.107498_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbiomolbio.2015.12.002","article-title":"Variability in cardiac electrophysiology: Using experimentally-calibrated populations of models to move beyond the single virtual physiological human paradigm","volume":"120","author":"Muszkiewicz","year":"2016","journal-title":"Progress in Biophysics and Molecular Biology"},{"key":"10.1016\/j.vascn.2024.107498_bb0180","first-page":"1476","article-title":"US agency seeks to phase out animal testing","volume":"409","author":"Nuwer","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vascn.2024.107498_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002061","article-title":"Simulation of the undiseased human cardiac ventricular action potential: Model formulation and experimental validation","volume":"7","author":"O'Hara","year":"2011","journal-title":"PLoS Computational Biology"},{"issue":"7","key":"10.1016\/j.vascn.2024.107498_bb0190","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1128\/AAC.42.7.1706","article-title":"Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin resistant pneumococcus in rabbits","volume":"42","author":"\u00d8stergaard","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.vascn.2024.107498_bb0195","article-title":"Computational investigation of drug-induced effects on human cardiac electro-mechanics","volume":"23 Supplement_3","author":"Passini","year":"2021","journal-title":"EP Europace"},{"issue":"5","key":"10.1016\/j.vascn.2024.107498_bb0200","first-page":"83","article-title":"Virtual thorough QT (TQT) trial-extrapolation of in vitro cardiac safety data to in vivo situation using multi-scale physiologically based ventricular cell-wall model exemplified with Tolterodine and Fesoterodine","volume":"20","author":"Patel","year":"2018","journal-title":"The American Association of Pharmaceutical Scientists Journal"},{"key":"10.1016\/j.vascn.2024.107498_bb0205","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fphys.2019.00721","article-title":"Comprehensive uncertainty quantification and sensitivity analysis for cardiac action potential models","volume":"10","author":"Pathmanathan","year":"2019","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.vascn.2024.107498_bb0210","doi-asserted-by":"crossref","first-page":"585400","DOI":"10.3389\/fphys.2020.585400","article-title":"Data-driven uncertainty quantification for cardiac electrophysiological models: Impact of physiological variability on action potential and spiral wave dynamics","volume":"11","author":"Pathmanathan","year":"2020","journal-title":"Frontiers in Physiology"},{"issue":"3","key":"10.1016\/j.vascn.2024.107498_bb0220","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ahj.2013.11.004","article-title":"Rechanneling of the cardiac proarrhythmia safety paradigm: A meeting report from the cardiac safety research consortium","volume":"167","author":"Sager","year":"2014","journal-title":"American Heart Journal"},{"key":"10.1016\/j.vascn.2024.107498_bb0225","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","article-title":"hERG potassium channels and cardiac arrhythmia","volume":"440","author":"Sanguinetti","year":"2006","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.vascn.2024.107498_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/cnm.3140","article-title":"Fully coupled fluid-electro-mechanical model of the human heart for supercomputers","volume":"34","author":"Santiago","year":"2018","journal-title":"International Journal for Numerical Methods in Biomedical Engineering"},{"issue":"suppl_2","key":"10.1016\/j.vascn.2024.107498_bb0235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/43.suppl_2.69","article-title":"Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: A comparison in humans and other mammalian species","volume":"43","author":"Siefert","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1016\/j.vascn.2024.107498_bb0240","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00003495-197815030-00001","article-title":"Verapamil: A review of its pharmacological properties and therapeutic use","volume":"15","author":"Singh","year":"1978","journal-title":"Drugs"},{"issue":"suppl_2","key":"10.1016\/j.vascn.2024.107498_bb0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/43.suppl_2.83","article-title":"Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man","volume":"43","author":"Stass","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"11","key":"10.1016\/j.vascn.2024.107498_bb0250","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4236\/jbise.2017.1011040","article-title":"Cardiomyocytes derived from human induced pluripotent stem cells: An in-vitro model to predict cardiac effects of drugs","volume":"10","author":"Sube","year":"2017","journal-title":"Journal of Biomedical Science and Engineering"},{"key":"10.1016\/j.vascn.2024.107498_bb0255","article-title":"Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac purkinje cells for proarrhythmia risk prediction","volume":"4","author":"Trovato","year":"2020","journal-title":"Frontiers in Toxicology"},{"issue":"Suppl. 2","key":"10.1016\/j.vascn.2024.107498_bb0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00003495-199958002-00006","article-title":"Pharmacokinetics and pharmacodynamics of fluoroquinolones","volume":"58","author":"Turnidge","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.vascn.2024.107498_bb0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jocs.2015.12.007","article-title":"Alya: Multiphysics engineering simulation toward exascale","volume":"14","author":"Vazquez","year":"2016","journal-title":"Journal of Computational Science"},{"key":"10.1016\/j.vascn.2024.107498_bb0270","author":"Verapamil"},{"issue":"4","key":"10.1016\/j.vascn.2024.107498_bb0275","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cpt.1303","article-title":"Assessment of multi-Ion Channel block in a phase I randomized study design: Results of the CiPA phase I ECG biomarker validation study","volume":"105","author":"Vicente","year":"2019","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.vascn.2024.107498_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056359","article-title":"mRNA expression levels in failing human hearts predict cellular electrophysiological remodeling: A population-based simulation study","volume":"8","author":"Walmsley","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vascn.2024.107498_bb0285","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/jps.24119","article-title":"Understanding and reducing the experimental variability of in vitro plasma protein binding measurements","volume":"103","author":"Wang","year":"2014","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.vascn.2024.107498_bb0290","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.hrthm.2008.09.008","article-title":"Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine","volume":"5","author":"Wu","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.vascn.2024.107498_bb0300","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fphys.2012.00360","article-title":"In silico prediction of sex-based differences in human susceptibility to cardiac ventricular tachyarrhythmias","volume":"3","author":"Yang","year":"2012","journal-title":"Frontiers in Physiology"},{"issue":"8","key":"10.1016\/j.vascn.2024.107498_bb0305","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/CIRCRESAHA.119.316404","article-title":"A computational pipeline to predict cardiotoxicity","volume":"126","author":"Yang","year":"2020","journal-title":"Circulation Research"},{"key":"10.1016\/j.vascn.2024.107498_bb0310","doi-asserted-by":"crossref","unstructured":"Okada, J.-i., Yoshinaga, T., Kurokawa, J., Washio, T., Furukawa, T., Sawada, K., Sugiura, S. & Hisada, T. Arrhythmic hazard map for a 3d whole-ventricle model under multiple ion channel block. British Journal of Pharmacology 175(17), 3435\u20133452 (2018).","DOI":"10.1111\/bph.14357"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687192400008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105687192400008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:06:03Z","timestamp":1761005163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105687192400008X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":58,"alternative-id":["S105687192400008X"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107498","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virtual clinical QT exposure-response studies \u2013 A translational computational approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2024.107498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107498"}}